BML-190 (BML190, IMMA, Indomethacin morpholinylamide)，又称吲哚美辛吗啉代酰胺，是一种氨烷基吲哚，是大麻素受体(CB2)的选择性配体，K_i为435 nM；作用于CB1受体的K_i为> 2 μM。大麻素受体CB2主要调节与免疫相关的各种疾病。

参考文献

[1] New DC, et al. BML-190 and AM251 act as inverse agonists at the human cannabinoid CB2 receptor: signalling via cAMP and inositol phosphates. FEBS Lett. 2003 Feb 11;536(1-3):157-60.

[2] Zhang Q, et al. In vitro metabolism of indomethacin morpholinylamide (BML-190), an inverse agonist for the peripheral cannabinoid receptor (CB(2)) in rat liver microsomes. Eur J Pharm Sci. 2010 Sep 11;41(1):163-72.

冰袋运输。粉末直接保存于-25~-15℃，有效期3年。建议分装后-25~-15℃干燥保存，避免反复冻融。